| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CELZ | Common Stock | Purchase | $3,050 | +5,000 | +20% | $0.6100 | 30,087 | 21 Sep 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $2,873 | +4,500 | +15% | $0.6385 | 34,587 | 21 Sep 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $314 | +500 | +1.4% | $0.6280 | 35,087 | 21 Sep 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $12,100 | +20,000 | +57% | $0.6050 | 55,087 | 21 Sep 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $6,480 | +12,000 | +22% | $0.5400 | 67,087 | 22 Sep 2022 | Direct | |
| holding | CELZ | Common Stock | 226,948 | 21 Sep 2022 | Entity | F1 |
| Id | Content |
|---|---|
| F1 | Owned by Creative Medical Health, Inc., of which Mr. Warbington serves as President and Chief Executive Officer. |